We observed an AD-associated, CD83(+) microglial subtype, which was present in 47% of neuropathologically defined AD subjects within the Banner SFG cohort, 25% of the Fujita-ROSMAP cohort, and 38% of the Mathys-ROSMAP cohort. Here, CD83 is linked to Alzheimer disease.